<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02383706</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00056786</org_study_id>
    <nct_id>NCT02383706</nct_id>
  </id_info>
  <brief_title>Obstructive Sleep Apnea in Pregnancy</brief_title>
  <acronym>OSAinPreg</acronym>
  <official_title>Obstructive Sleep Apnea in Pregnancy: Development of a Pregnancy-Specific Screening Tool</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obstructive sleep apnea (OSA) is a risk factor for complications during pregnancy and current
      screening tools for OSA have not been shown to be reliable in pregnant women. The primary aim
      of this study is to develop a valid screening tool to identify at-risk pregnant women, so
      that they can be further evaluated and treated. Women with OSA may also be at risk for
      respiratory complications related to opiate administration for post-cesarean delivery pain. A
      secondary aim of this study is to evaluate post-operative minute ventilation in women who
      undergo cesarean delivery using a novel method of non-invasive minute ventilation monitoring.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Following recruitment and informed consent, subjects will complete 3 screening questionnaires
      for OSA: the Berlin and STOP-BANG questionnaires, and the Epworth Sleepiness Scale. They will
      also undergo a physical exam by one of the study investigators including examination of the
      neck and upper airway to assess neck circumference, retrognathia, thyromental space, tongue
      scalloping, MMS, modified MMS, tonsil size and lateral pharyngeal wall narrowing.

      Subjects will all receive ApneaLink™ Air (ResMed, Poway, CA), a FDA-approved, non-invasive,
      portable, home polysomnography device, and instructions for using the device during one night
      of sleep. They will be given contact information if they have questions regarding use of the
      device. Subjects will receive a prepaid FedEx envelope to return the device. They will
      receive a parking voucher worth up to a maximum of $7 during this appointment. Subjects will
      be compensated ($50 check by mail) once the device is received. A follow-up phone call will
      be made by the PI to inform the subject of the results of the home polysomnography study.
      Subjects who screen positive (AHI &gt; 5) by home polysomnography will be referred to Duke Sleep
      Medicine for further evaluation. Pregnancy outcomes will be followed for all subjects.

      Enrolled subjects who go on to have a cesarean delivery will be studied using ExSpiron
      (Respiratory Motion, Inc., Waltham, MA), a FDA-approved, non-invasive respiratory volume
      monitor for 24 hours. The monitor has three adhesive pads that attach to the chest wall and a
      cord that attaches to the monitoring device, similar to an electrocardiogram. The monitor can
      be detached and the study suspended when patients ambulate to the restroom, and should not
      interfere with breastfeeding. The monitor will be connected to the patient in the
      pre-operative holding area, and the monitor will be calibrated with baseline spirometry
      measurements using a Wright spirometer over one minute. The subject will wear the device for
      the duration of the surgery, in the recovery room, and for 24 following surgery. The
      non-invasive respiratory volume monitor will be collected by study personnel at the
      conclusion of the 24 hours, and no data collected from the monitor will be used for clinical
      decision-making. Standard of care will be followed for the antepartum, intrapartum and
      postpartum management of those patients. Patients will continue to be monitored using the
      investigators' standard protocol for patients who have received neuraxial morphine which
      consists of continuous monitoring for 2 hours, followed by monitoring every 2 hours for 24
      hours of the following: vital signs, oxygen saturation, respiratory rate, pain score and
      sedation score. The investigators also have nursing standing orders for naloxone
      administration for respiratory rate &lt; 8 breaths/min or Richmond Agitation Sedation Scale
      (RASS) ≤ -3, together with immediate notification of medical staff, as well an order to
      notify medical staff for oxygen saturation &lt; 90% or RASS &lt; -2.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2015</start_date>
  <completion_date type="Actual">August 2017</completion_date>
  <primary_completion_date type="Actual">May 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With a Negative Obstructive Sleep Apnea (OSA) Home Sleep Test Result</measure>
    <time_frame>Women studied at one time point between 24 weeks and 35 weeks gestation.</time_frame>
    <description>Determined using the Apnea-Hypopnea Index (AHI). Participants were considered OSA-negative if experienced less than five events per hour.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With a Positive Obstructive Sleep Apnea (OSA) Home Sleep Test Result</measure>
    <time_frame>Women studied at one time point between 24 weeks and 35 weeks gestation.</time_frame>
    <description>Determined using the Apnea-Hypopnea Index (AHI). Participants were considered OSA-positive if experienced five or more events per hour.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post-op Minute Ventilation Following C-section</measure>
    <time_frame>Women studied for 24-hours following their cesarean delivery.</time_frame>
    <description>To evaluate post-operative minute ventilation in women who undergo cesarean delivery using a novel method of non-invasive minute ventilation monitoring</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">108</enrollment>
  <condition>Sleep Apnea, Obstructive</condition>
  <condition>Pregnancy</condition>
  <condition>Obesity, Morbid</condition>
  <arm_group>
    <arm_group_label>Subjects</arm_group_label>
    <description>Pregnant women, BMI greater than or equal to 40 undergo questionnaires, physical exam, and ApneaLink Air, at home, overnight polysomnography study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ApneaLink Air</intervention_name>
    <description>Overnight, home polysomnography device</description>
    <arm_group_label>Subjects</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Berlin Quesionnaire</intervention_name>
    <description>OSA screening questionnaire</description>
    <arm_group_label>Subjects</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Epworth Sleepiness Scale</intervention_name>
    <description>OSA screening questionnaire</description>
    <arm_group_label>Subjects</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>STOP-BANG questionnaire</intervention_name>
    <description>OSA screening questionnaire</description>
    <arm_group_label>Subjects</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Physical exam</intervention_name>
    <description>Physical exam of neck, mouth and upper airway</description>
    <arm_group_label>Subjects</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant women, ages 18-50 years old, BMI &gt; or equal to 40 kg/m2, without a prior diagnosis
        of obstructive sleep apnea or chronic narcotic use.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  gestational age 24 to 35 weeks

          -  BMI &gt; or equal to 40 kg/m2

          -  18 years or older

        Exclusion Criteria:

          -  Non-English speaking subjects

          -  Established diagnosis of OSA

          -  chronic narcotic use
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 4, 2015</study_first_submitted>
  <study_first_submitted_qc>March 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 9, 2015</study_first_posted>
  <results_first_submitted>November 28, 2018</results_first_submitted>
  <results_first_submitted_qc>March 19, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">June 19, 2019</results_first_posted>
  <last_update_submitted>March 19, 2019</last_update_submitted>
  <last_update_submitted_qc>March 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sleep Apnea, Obstructive</keyword>
  <keyword>Pregnancy</keyword>
  <keyword>Obesity, Morbid</keyword>
  <keyword>Complications, pregnancy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 1, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/06/NCT02383706/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Subjects</title>
          <description>Pregnant women, BMI greater than or equal to 40 undergo questionnaires, physical exam, and ApneaLink Air, at home, overnight polysomnography study.
ApneaLink Air: Overnight, home polysomnography device
Berlin Quesionnaire: OSA screening questionnaire
Epworth Sleepiness Scale: OSA screening questionnaire
STOP-BANG questionnaire: OSA screening questionnaire
Physical exam: Physical exam of neck, mouth and upper airway</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="108"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="80"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Participants who completed the study.</population>
      <group_list>
        <group group_id="B1">
          <title>Subjects</title>
          <description>Pregnant women, BMI greater than or equal to 40 undergo questionnaires, physical exam, and ApneaLink Air, at home, overnight polysomnography study.
ApneaLink Air: Overnight, home polysomnography device
Berlin Quesionnaire: OSA screening questionnaire
Epworth Sleepiness Scale: OSA screening questionnaire
STOP-BANG questionnaire: OSA screening questionnaire
Physical exam: Physical exam of neck, mouth and upper airway</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="80"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <population>Reported separately for participants with Obstructive Sleep Apnea and those without.</population>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <title>No Obstructive Sleep Apnea</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="61"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27" lower_limit="26" upper_limit="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Obstructive Sleep Apnea</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="19"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33" lower_limit="29" upper_limit="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>All subjects</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29.5" lower_limit="24" upper_limit="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="80"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="78"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="52"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Pre-pregnancy Body Mass Index (BMI)</title>
          <population>Reported separately for participants with Obstructive Sleep Apnea and those without.</population>
          <units>kg/m^2</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <title>Obstructive Sleep Apnea</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="19"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53" lower_limit="45" upper_limit="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No Obstructive Sleep Apnea</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="61"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45" lower_limit="41" upper_limit="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>All subjects</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46" lower_limit="42" upper_limit="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With a Negative Obstructive Sleep Apnea (OSA) Home Sleep Test Result</title>
        <description>Determined using the Apnea-Hypopnea Index (AHI). Participants were considered OSA-negative if experienced less than five events per hour.</description>
        <time_frame>Women studied at one time point between 24 weeks and 35 weeks gestation.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Subjects</title>
            <description>Pregnant women, BMI greater than or equal to 40 undergo questionnaires, physical exam, and ApneaLink Air, at home, overnight polysomnography study.
ApneaLink Air: Overnight, home polysomnography device Berlin Quesionnaire: OSA screening questionnaire Epworth Sleepiness Scale: OSA screening questionnaire STOP-BANG questionnaire: OSA screening questionnaire Physical exam: Physical exam of neck, mouth and upper airway</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With a Negative Obstructive Sleep Apnea (OSA) Home Sleep Test Result</title>
          <description>Determined using the Apnea-Hypopnea Index (AHI). Participants were considered OSA-negative if experienced less than five events per hour.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="80"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With a Positive Obstructive Sleep Apnea (OSA) Home Sleep Test Result</title>
        <description>Determined using the Apnea-Hypopnea Index (AHI). Participants were considered OSA-positive if experienced five or more events per hour.</description>
        <time_frame>Women studied at one time point between 24 weeks and 35 weeks gestation.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Subjects</title>
            <description>Pregnant women, BMI greater than or equal to 40 undergo questionnaires, physical exam, and ApneaLink Air, at home, overnight polysomnography study.
ApneaLink Air: Overnight, home polysomnography device
Berlin Quesionnaire: OSA screening questionnaire
Epworth Sleepiness Scale: OSA screening questionnaire
STOP-BANG questionnaire: OSA screening questionnaire
Physical exam: Physical exam of neck, mouth and upper airway</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With a Positive Obstructive Sleep Apnea (OSA) Home Sleep Test Result</title>
          <description>Determined using the Apnea-Hypopnea Index (AHI). Participants were considered OSA-positive if experienced five or more events per hour.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="80"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Post-op Minute Ventilation Following C-section</title>
        <description>To evaluate post-operative minute ventilation in women who undergo cesarean delivery using a novel method of non-invasive minute ventilation monitoring</description>
        <time_frame>Women studied for 24-hours following their cesarean delivery.</time_frame>
        <population>Data not collected</population>
        <group_list>
          <group group_id="O1">
            <title>Subjects</title>
            <description>Pregnant women, BMI greater than or equal to 40 undergo questionnaires, physical exam, and ApneaLink Air, at home, overnight polysomnography study.
ApneaLink Air: Overnight, home polysomnography device
Berlin Quesionnaire: OSA screening questionnaire
Epworth Sleepiness Scale: OSA screening questionnaire
STOP-BANG questionnaire: OSA screening questionnaire
Physical exam: Physical exam of neck, mouth and upper airway</description>
          </group>
        </group_list>
        <measure>
          <title>Post-op Minute Ventilation Following C-section</title>
          <description>To evaluate post-operative minute ventilation in women who undergo cesarean delivery using a novel method of non-invasive minute ventilation monitoring</description>
          <population>Data not collected</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From time of enrollment until delivery, no longer than 6 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Subjects</title>
          <description>Pregnant women, BMI greater than or equal to 40 undergo questionnaires, physical exam, and ApneaLink Air, at home, overnight polysomnography study.
ApneaLink Air: Overnight, home polysomnography device
Berlin Quesionnaire: OSA screening questionnaire
Epworth Sleepiness Scale: OSA screening questionnaire
STOP-BANG questionnaire: OSA screening questionnaire
Physical exam: Physical exam of neck, mouth and upper airway</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="108"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="108"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="108"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>80 subjects Home sleep testing used Low acceptance of home sleep test by subjects (28 subjects did not wear device more than 2 hours) One time point in pregnancy</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr Jennifer Dominguez</name_or_title>
      <organization>Duke University Medical Center</organization>
      <phone>(919) 668-2024</phone>
      <email>jennifer.dominguez@dm.duke.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

